FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to producing subunit vaccines against Mycoplasma spp.; it can be used in medicine for the prevention of Mycoplasma spp. infection. Vaccine compositions based on EutD protein with SEQ ID NO: 10 in combination with a pharmaceutically acceptable adjuvant or pharmaceutically acceptable additive are proposed.
EFFECT: invention provides for strong immune effects against Mycoplasma spp.
6 cl, 4 dwg, 9 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
MICROORGANISMS PRODUCING L-VALINE, AND METHOD OF PRODUCING L-VALINE USING SAME | 2021 |
|
RU2822660C1 |
SOLUBILIZED APIRASES, METHODS AND APPLICATIONS | 2019 |
|
RU2791992C2 |
NEW O-SUCCINYL HOMOSERINE TRANSFERASE VARIANT AND METHOD FOR SYNTHESIS OF O-SUCCINYL HOMOSERINE USING SAID VARIANT | 2018 |
|
RU2747493C1 |
NEW FISH CORONAVIRUS | 2020 |
|
RU2813731C2 |
SIALYLTRANSFERASES AND USE THEREOF IN PRODUCING SIALYLATED OLIGOSACCHARIDES | 2018 |
|
RU2822039C2 |
NEW O-SUCCINYL HOMOSERINE TRANSFERASE MUTANT AND METHOD FOR SYNTHESIS OF O-SUCCINYL HOMOSERINE USING SAID MUTANT | 2018 |
|
RU2747494C1 |
VARIANT OF ACETOHYDROXY ACID SYNTHASE, MICROORGANISM CONTAINING SAME, AND METHOD FOR PRODUCING AMINO ACID WITH 1ST BRANCHED CHAIN | 2018 |
|
RU2743964C1 |
NEW VARIANT OF L-TYROSINE-EXPORTING PROTEIN AND METHOD OF OBTAINING L-TYROSINE USING IT | 2021 |
|
RU2808831C1 |
BCMA-TARGETED ANTIBODY AND ITS USE | 2018 |
|
RU2799655C2 |
INHIBITING GENE EXPRESSION IN INSECT PESTS | 2018 |
|
RU2725953C2 |
Authors
Dates
2021-11-12—Published
2019-07-08—Filed